Truveta’s Comparative Study on Weight Loss Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Patients
Truveta's new research explored the effectiveness of semaglutide (Ozempic) and tirzepatide (Mounjaro) in weight loss among [...]
AstraZeneca Acquires Obesity Drug Developer Eccogene’s ECC5004 for $185 Million, Aiming at Type 2 Diabetes and Obesity Markets
AstraZeneca is acquiring obesity drug developer Eccogene's ECC5004 for $185 million with the potential to pay [...]
Global Planning to Local Execution Market Success
Moving beyond static evidence development to ensure local market access success; responding to recent changes in governmental drug regulations [...]
Research Reveals Small Risk of Severe Stomach Problems for Users of Novo Nordisk’s Weight-Loss Drugs
Research conducted by the University of British Columbia and published in the Journal of the American Medical Association suggests a [...]
FDA Advisory Panel Backs Removal of Non-Circulating Flu Strain from Vaccines, Amid Timeline Concerns
The FDA's vaccine advisory panel has supported removing a strain of influenza viruses that no longer circulates, known as B/Yamagata, [...]
Trends Projected to Reshape the Healthcare Landscape in 2024
Several societal drivers will shape the healthcare landscape in 2024, including a longer-living population, transformative technologies, and global economic uncertainty. [...]
2023 Nobel Prize in Medicine Awarded to mRNA Researchers Katalin Karikó and Drew Weissman
Katalin Karikó and Drew Weissman, two pioneers of mRNA research, were awarded the 2023 Nobel Prize in Medicine or Physiology [...]
Johnson & Johnson’s Drug Combination Improves Progression-Free Survival in Lung Cancer Trial Against AstraZeneca’s Therapy
The Mariposa study showed that a combination of two Johnson & Johnson (J&J) drugs, Rybrevant, and lazertinib, was successful in [...]
Unveiling the NHS Data Landscape: First Comprehensive Mapping for Improved Transparency and Efficiency
Researchers from the Institute of Global Health Innovation at Imperial College London have mapped and evaluated all electronic data flows [...]
Roche Acquires Two RNA-Targeted Drug Programs for Alzheimer’s and Huntington’s from Ionis Pharmaceuticals
Roche has obtained two RNA-targeted drug programs for Alzheimer's and Huntington's diseases from Ionis Pharmaceuticals. The deal involves a $60 [...]
GA4GH Announces Ten New International Genomic Data Initiatives
The Global Alliance for Genomics and Health (GA4GH) has announced ten new international genomic data initiatives, [...]
Risk of Long Covid Increases with Each COVID-19 Reinfection, Indicates Study
The coronavirus pandemic has prompted questions about reinfection and the risk of developing "long Covid" characterized [...]
California Legislature Approves Bills for 10,000 New Beds and Expanded Drug Addiction Treatment to Address Homelessness and Drug Crises
The California Legislature has approved two bills that aim to address the state's homelessness and drug [...]
Polio Eradication Goals for 2023 Likely To Be Missed: Insights from the Independent Monitoring Board
According to a report by the polio program's Independent Monitoring Board, the Global Polio Eradication Initiative [...]
Cognitive Ability Tied to COVID-19 Vaccination Rates
The study published in the Journal of Health Economics investigated a link between an individual's cognitive [...]
Advancements in Healthcare: The Influential Roles of Artificial Intelligence and Data Science
The last decade in healthcare has seen notable advancements due to artificial intelligence (AI), particularly data science. By using data-driven [...]
Updates to Keep an Eye on
The FDA has fast-tracked approval of Pfizer's Elfrexfio drug for hard-to-treat multiple myeloma, offering new hope to patients. State and [...]
Sarepta Therapeutics Begins Dosing Duchenne Patients with Newly Approved Gene Therapy
Sarepta Therapeutics has started dosing Duchenne muscular dystrophy patients with its recently approved gene therapy, Elevidys, and plans to serve [...]
Cost and Accessibility Concerns Over Lecanemab
The first drug aiming to slow the progression of Alzheimer's, lecanemab (brand name Leqembi), could cost the U.S. health care [...]
Millennials and Gen Z More Likely to Buy from Brands Promoting Healthy Lifestyle
According to a DirecTV Advertising report, Millennials and Gen Z are more inclined towards brands promoting a healthy lifestyle than [...]
Infectious Disease Market Projected to Grow by 5.7% Led by Pfizer, Gilead Sciences, and GSK
According to a report by GlobalData, the infectious disease market is projected to grow actively from 2023 to 2029 and [...]
Groundbreaking Alliance: RetinAI Medical AG Joins Forces with Retina Consultants of America!
RetinAI Medical AG (RetinAI) and Retina Consultants of America (RCA) are partnering to advance artificial intelligence (AI) applications in the [...]
Medlinker’s AI Doctors Almost Match Human Physicians in Groundbreaking Live Test
Medlinker, a Chinese digital healthcare company, hosted a live comparison of its AI doctors, MedGPT, and human doctors in Chengdu, [...]
ITIF Report: Global Drug Price Controls Restrict Pharmaceutical Research and Development
The Information Technology and Innovation Foundation (ITIF) study reports that drug price controls in non-US Organization for Economic Cooperation and [...]
Economists Suggest That Universal Coverage Is Already Possible for the US: What Obstacles Still Stand in the Way?
The current state of health insurance in the U.S. needs to be revised, even for insured Americans who face the [...]
